21 results
8-K
EX-99.1
AUPH
Aurinia Pharmaceuticals Inc
5 Jan 24
Aurinia Provides Preliminary Unaudited Fourth Quarter and Full-year 2023 Net Revenue Results
6:02am
and individuals of Hispanic ancestry are approximately twice as likely to develop the disease when compared with Caucasian individuals. Black and Hispanic
8-K
EX-99.1
AUPH
Aurinia Pharmaceuticals Inc
2 Nov 23
Aurinia Pharmaceuticals Reports Third Quarter and Nine Months 2023 Financial and Operational Results
6:01am
to develop lupus nephritis and Hispanic people are approximately twice as likely to develop the disease compared to White people with SLE. Black … and Hispanic people with SLE also tend to develop lupus nephritis earlier and have poorer outcomes, compared to White people with SLE.
About Aurinia
8-K
EX-99.1
AUPH
Aurinia Pharmaceuticals Inc
3 Aug 23
Aurinia Pharmaceuticals Reports Second Quarter and Six Months 2023 Financial and Operational Results
6:03am
and Hispanic people are approximately twice as likely to develop the disease compared to White people with SLE. Black and Hispanic people with SLE also tend
8-K
EX-99.1
AUPH
Aurinia Pharmaceuticals Inc
4 May 23
Aurinia Pharmaceuticals Reports First Quarter 2023 Financial and Operational Results
6:06am
the kidney. Black and Asian people with SLE are four times more likely to develop lupus nephritis and Hispanic people are approximately twice as likely … to develop the disease compared to White people with SLE. Black and Hispanic people with SLE also tend to develop lupus nephritis earlier and have
8-K
EX-99.1
AUPH
Aurinia Pharmaceuticals Inc
5 Apr 23
Aurinia Pharmaceuticals Announces Promising Topline Data from Renal Biopsy Sub-study of the AURORA Trial
8:16am
with SLE are four times more likely to develop lupus nephritis and Hispanic people are approximately twice as likely to develop the disease
compared … to White people with SLE. Black and Hispanic people with SLE also tend to develop lupus nephritis earlier and have poorer outcomes, compared to White
8-K
EX-99.1
4o1e7v
3 Nov 22
Aurinia Reports Third Quarter and Nine Months 2022 Financial and Operational Results
6:04am
8-K
EX-99.1
v8jmpaii749m68
4 Aug 22
Aurinia Reports Second Quarter and Six Months 2022 Financial and Operational Results
6:07am
8-K
EX-99.1
2jq3gpemgx
10 May 22
Aurinia Reports First Quarter 2022 Financial and Operational Results
6:06am
8-K
EX-99.1
x5nl5qxw
28 Feb 22
Aurinia Reports Fourth Quarter and Full Year 2021 Financial Results and Company Updates
6:08am
8-K
EX-99.1
2xa7vc37mhqvfi 5ei9
3 Nov 21
Aurinia Reports Third Quarter and Nine Months 2021 Financial Results and Company Updates
12:00am
8-K
EX-99.1
lhebepkiukj5rp
5 Aug 21
Aurinia Reports Second Quarter and Six Months 2021 Financial Results and Recent Operational Highlights
4:12pm
8-K
EX-99.1
8aacq
5 Aug 21
Aurinia Reports Second Quarter and Six Months 2021 Financial Results and Recent Operational Highlights
4:11pm
8-K
EX-99.1
qvcnuo8 s4wm8
25 Jun 21
Regulation FD Disclosure
4:12pm
8-K
EX-99.1
l81mb4f3 q0tybk7qep
6 May 21
Aurinia Reports First Quarter 2021 Financial Results and Recent Operational Highlights
4:08pm
8-K
EX-99.1
oltcvvocvp1ente
24 Feb 21
Aurinia Reports Fourth Quarter and Full Year 2020 Financial Results and Recent Operational Highlights
4:14pm
8-K
EX-99.2
vujnv8na6ink2mcdcv
25 Jan 21
Financial Statements and Exhibits
8:21am
8-K
EX-99.1
q9n3r74
25 Jan 21
Financial Statements and Exhibits
8:21am
6-K
EX-99.1
kpv418
22 Oct 20
Aurinia Pharmaceuticals Inc. 6-K
5:15pm
6-K
EX-99.1
tczbk5su
5 Jun 20
Aurinia Pharmaceuticals Inc. 6-K
7:05am